Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
The biotechnology environment
The recent changes in the Government seems to have excited the industry but the real test will be to see if the enthusiasm…
Forging India’s bioeconomy
Without the support of its government, the Indian biotech industry may not be able to achieve its high potential, say James…
Wake up call for Indian pharma
Unless Indian pharma companies wake up to the new “patent challenge” regime, they could “miss the bus”, opines Dr Gopakumar G…
DRL launches docetaxel injection in US
Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose
‘In increasingly crowded markets like India, a recognised and trusted corporate brand is critical’
After the hiving off of its proprietary pharmaceuticals business, about half of the new Abbott’s business is either direct to…
Aurobindo Pharma to buy Natrol for $132.5 million
Emerges as the highest and best bidder to acquire the California-based company
Venus gets marketing authorisation for Meropenem
Meropenem is a last-resort drug of the carbapenem class of antibiotics which is used in intensive care units (ICUs) of hospitals
US FDA committee votes against Novartis’ multiple myeloma lead
FDA not bound to follow Committee's guidance its review of LBH589 NDA
Glenmark receives final ANDA approval for Omeprazole DR capsules
It is a generic version of Prilosec by AstraZeneca
India pharma companies well positioned for global growth
Failure to comply with the stringent quality requirements in developed markets is a key risk